Medpage Today on MSN3d
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files Suit
In Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
The Pharma Letter5h
Lilly's Ebglyss demonstrated meaningful improvement in eczema
New results show Eli Lilly Ebglyss (lebrikizumab-lbkz) improved skin (including hand and face) and itch among patients with ...
Roche comes out against allowing takeover of drug manufacturer Catalent
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
Can Roche Challenge Lilly and Novo in the Weight Loss Market?
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
FiercePharma2d
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
The groups behind the letter alleged that Novo Nordisk’s plant purchases could hinder not only the Danish drugmaker’s chief ...
KSL2d
Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
Analysis
Can Roche Holding Challenge Eli Lilly, Novo Nordisk in Weight Loss Market?
Eli Lilly and Company, Novo Nordisk A/S, Roche Holding Ltd ADR, Structure Therapeutics Inc ADR. Read MarketBeat.com (Leo Miller)'s latest article on Investing.com ...